Corporate Social Responsibility

Adhere To The Principle Of Sustainable Development To Create A Better Life

Joincare Pharmaceutical Group Industry Co., Ltd. Board of Directors Diversity Policy

Published Time:

2024-08-27

Chapter 1 General Provisions

Article 1   For the purpose of achieving the diversification of the board of directors of Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as "the Company"), this Company's Board of Directors' Diversity Policy (hereinafter referred to as "this Policy") is formulated in accordance with relevant laws and regulations of the People's Republic of China, such as the Company Law of the People's Republic of China, and the Articles of Association of Joincare Pharmaceutical Group Industry Co., Ltd. for compliance.

 

Chapter 2 Policy Philosophy

Article 2 The Company recognizes the importance of board diversity for effective corporate governance and board operations.

Article 3 To achieve sustainable and balanced development, the Company regards increasing diversity at the board level as a key element in supporting it in achieving its strategic goals and maintaining sustainable development. All board appointments are based on merit, and the benefits of board diversity are fully considered when considering candidates, with appropriate conditions.

Article 4 The Company is committed to selecting the best candidates for board members. Candidate selection will be based on a range of diversity criteria, including, but not limited to, gender, age, nationality, cultural background, and ethnicity, in addition to educational background, professional experience, skills, knowledge, and tenure. The final decision will be based on the candidate's strengths and contributions to the board.

Article 5 The Company's Nomination Committee (hereinafter referred to as the "Nomination Committee") is primarily responsible for identifying qualified candidates for directors and fully considering the Board Diversity Policy in the selection process, monitoring the implementation of this Policy and reviewing and revising it as appropriate implementation of this Policy to ensure its effectiveness. The appointment of all board members will fully consider the benefits of board diversity, fully consider the strengths of each candidate, and proceed according to objective standards.

 

Chapter 3 Supervision and Reporting

Article 6 The Nomination Committee will review this Policy as appropriate to ensure its effectiveness. The Nomination Committee will discuss amendments to this Policy as necessary.

 

Article Chapter 4 Disclosure of this Policy

Article Article 7 This Policy will be published on the Company's website as public information. A summary of this Policy and any measurable targets and progress towards achieving them set for the implementation of this Policy will be disclosed annually in the Sustainability Report.

 

Article Chapter 4 5

Article Supplementary Provisions Article 8 implementation of this Policy The Company will continuously monitor relevant policies and development trends on board diversity at home and abroad, and review and improve implementation of this Policy to enhance the effectiveness of sustainable development. If it conflicts with laws, administrative regulations, normative documents promulgated by the state in the future, or the Articles of Association as amended through legal procedures, it shall be implemented in accordance with the provisions of relevant national laws, administrative regulations, normative documents, or the Articles of Association, and revised if necessary implementation of this Policy

 

 

 

Joincare Pharmaceutical Group Industry Co., Ltd.

August 27, 2024